A key development was its approval and launch in India in September 2023, marking a significant entry into a high-potential market with a rising diabetes and obesity burden
13, the ROS scavenging ratio of G/D-CuP exceeded 95% at different concentrations, indicating a potential beneficial antioxidant effect for treating diabetic wounds
This is due to a variety of issues, from procurement, supply chain, and financial coverage, to the accessibility, affordability and availability of GLP-1 receptor agonists [which] remain highly inadequate to meet the population-level needs. Mind the evidence gap Despite the plethora of short-term evidence for GLP-1s in the management of weight loss, almost nothing is known about the possible long-term effects of these artificial peptide hormones
The reservoir of the monoclinic crystals contained 15% PEG 4000, and the reservoir of orthorhombic crystals contained 15% PEG 6000, MES 0.1 M, pH 6.5